Compare, Analyse Sanofi India with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs TEVA PHARMA (Israel) - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SANOFI INDIA   TEVA PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
TEVA PHARMA
Dec-13
SANOFI INDIA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs6,8403,131-   
Low Rs4,6302,720-   
Sales per share (Unadj.) Rs1,203.11,796.9-  
Earnings per share (Unadj.) Rs165.3112.2-  
Cash flow per share (Unadj.) Rs209.9257.5-  
Dividends per share (Unadj.) Rs84.0098.26-  
Dividend yield (eoy) %1.53.4 43.6%  
Book value per share (Unadj.) Rs963.61,996.0-  
Shares outstanding (eoy) m23.03848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.81.6 292.8%   
Avg P/E ratio x34.726.1 133.2%  
P/CF ratio (eoy) x27.311.4 240.5%  
Price / Book Value ratio x6.01.5 406.1%  
Dividend payout %50.887.5 58.1%   
Avg Mkt Cap Rs m132,0782,480,731 5.3%   
No. of employees `0003.344.9 7.3%   
Total wages/salary Rs m4,0680-   
Avg. sales/employee Rs Th8,393.833,902.6 24.8%   
Avg. wages/employee Rs Th1,232.40-   
Avg. net profit/employee Rs Th1,153.02,117.9 54.4%   
INCOME DATA
Net Sales Rs m27,7081,523,753 1.8%  
Other income Rs m8970-   
Total revenues Rs m28,6051,523,753 1.9%   
Gross profit Rs m6,235417,281 1.5%  
Depreciation Rs m1,027123,166 0.8%   
Interest Rs m729,929 0.0%   
Profit before tax Rs m6,098264,185 2.3%   
Minority Interest Rs m01,200 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-173,423 0.0%   
Tax Rs m2,292-3,225 -71.1%   
Profit after tax Rs m3,80695,188 4.0%  
Gross profit margin %22.527.4 82.2%  
Effective tax rate %37.6-1.2 -3,078.6%   
Net profit margin %13.76.2 219.9%  
BALANCE SHEET DATA
Current assets Rs m15,9221,029,137 1.5%   
Current liabilities Rs m6,235897,495 0.7%   
Net working cap to sales %35.08.6 404.7%  
Current ratio x2.61.1 222.7%  
Inventory Days Days6491 70.1%  
Debtors Days Days2196 21.8%  
Net fixed assets Rs m7,539497,691 1.5%   
Share capital Rs m2303,751 6.1%   
"Free" reserves Rs m21,9620-   
Net worth Rs m22,1921,692,601 1.3%   
Long term debt Rs m0779,129 0.0%   
Total assets Rs m29,8393,482,264 0.9%  
Interest coverage x872.19.8 8,874.9%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.90.4 212.2%   
Return on assets %12.83.6 355.7%  
Return on equity %17.25.6 305.0%  
Return on capital %27.54.9 557.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4420-   
CASH FLOW
From Operations Rs m3,739242,807 1.5%  
From Investments Rs m-731-86,036 0.8%  
From Financial Activity Rs m-1,972-291,264 0.7%  
Net Cashflow Rs m1,036-134,493 -0.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 75.01 Rs / USD

Compare SANOFI INDIA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare SANOFI INDIA With: VENUS REMEDIES  DR. REDDYS LAB  PIRAMAL ENTERPRISES  SUVEN LIFE SCIENCES  DR. DATSONS LABS  



Today's Market

Infosys Q4FY21 Results, HDFC Bank to Raise Rs 500 Billion, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a positive note yesterday, helped by gains in metals and banking stocks.

Related Views On News

SANOFI INDIA Announces Quarterly Results (2QFY21); Net Profit Up 5.0% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 5.0% YoY). Sales on the other hand came in at Rs 7 bn (down 11.9% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY21); Net Profit Up 39.9% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 39.9% YoY). Sales on the other hand came in at Rs 7 bn (down 5.0% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On... (Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

Why the Market Fell Yesterday (Fast Profits Daily)

Apr 6, 2021

In this video, I'll tell you the two reasons why the market fell on Monday and how you can prepare yourself for such events in the future.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

India's Revival: A Once-in-a-generation Wealth Making Opportunity
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SANOFI INDIA SHARE PRICE


Apr 15, 2021 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SANOFI INDIA

SANOFI INDIA - SUN PHARMA COMPARISON

COMPARE SANOFI INDIA WITH

FEATURED VIDEOS

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

More Featured Videos

MARKET STATS